Page last updated: 2024-08-23

alovudine and Local Neoplasm Recurrence

alovudine has been researched along with Local Neoplasm Recurrence in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broccoli, A; Fanti, S; Fonti, C; Lambertini, A; Lodi, F; Nanni, C; Pellegrini, C; Stefoni, V; Zanoni, L; Zinzani, PL1
Eary, JF; Hoffman, JM; Krohn, KA; Link, JM; Muzi, M; Spence, AM1
Been, LB; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ; van der Laan, BF1
Boin, C; Bousquet, G; Cuvier, C; EspiƩ, M; Giacchetti, S; Groheux, D; HindiƩ, E; Misset, JL; Moretti, JL; Teyton, P1
Horky, LL; Treves, ST1
Krause, BJ; Lordick, F; Ott, K1
Chen, J; Xu, T1
Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van der Laan, BF1
Arulampalam, TH; Costa, DC; Croasdale, I; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Visvikis, D1
Bussink, J; Kaanders, JH; Marres, HA; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ; Vogel, WV1

Reviews

4 review(s) available for alovudine and Local Neoplasm Recurrence

ArticleYear
[PET/CT in breast cancer: an update].
    Bulletin du cancer, 2009, Volume: 96, Issue:11

    Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Treatment Outcome

2009
PET and SPECT in brain tumors and epilepsy.
    Neurosurgery clinics of North America, 2011, Volume: 22, Issue:2

    Topics: Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Epilepsy; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Humans; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2011
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:20

    Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2011
Recent therapeutic advances and insights of recurrent glioblastoma multiforme.
    Frontiers in bioscience (Landmark edition), 2013, 01-01, Volume: 18, Issue:2

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Dideoxynucleosides; Glioblastoma; Humans; Immunotherapy; Interleukin-13 Receptor alpha2 Subunit; Neoplasm Recurrence, Local; Radiosurgery; Reoperation; Temozolomide

2013

Trials

3 trial(s) available for alovudine and Local Neoplasm Recurrence

ArticleYear
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:8

    Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity

2019
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
    Molecular imaging and biology, 2008, Volume: 10, Issue:5

    Topics: Adult; Biomarkers; Carbon Dioxide; Cell Proliferation; Creatine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Glioma; Humans; Male; Middle Aged; National Cancer Institute (U.S.); Neoplasm Recurrence, Local; Positron-Emission Tomography; Potassium; United States

2008
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Pseudolymphoma; Radiopharmaceuticals; Treatment Outcome

2007

Other Studies

3 other study(ies) available for alovudine and Local Neoplasm Recurrence

ArticleYear
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Oral oncology, 2009, Volume: 45, Issue:12

    Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity

2009
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2

    Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Dideoxynucleosides; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed

2004
Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:6

    Topics: Antineoplastic Agents; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome

2004